| Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 R Lozano, M Naghavi, K Foreman, S Lim, K Shibuya, V Aboyans, ... The lancet 380 (9859), 2095-2128, 2012 | 18089 | 2012 |
| Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 CJL Murray, T Vos, R Lozano, M Naghavi, AD Flaxman, C Michaud, ... The lancet 380 (9859), 2197-2223, 2012 | 11310 | 2012 |
| Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 T Vos, AD Flaxman, M Naghavi, R Lozano, C Michaud, M Ezzati, ... The lancet 380 (9859), 2163-2196, 2012 | 10218 | 2012 |
| Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic … MH Forouzanfar, A Afshin, LT Alexander, HR Anderson, ZA Bhutta, ... The lancet 388 (10053), 1659-1724, 2016 | 7916 | 2016 |
| Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic … T Vos, RM Barber, B Bell, A Bertozzi-Villa, S Biryukov, I Bolliger, ... The lancet 386 (9995), 743-800, 2015 | 7057 | 2015 |
| Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study GA Roth, GA Mensah, CO Johnson, G Addolorato, E Ammirati, ... Journal of the American college of cardiology 76 (25), 2982-3021, 2020 | 6342* | 2020 |
| Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of … S Abdalla, F Abd-Allah, MI Abdel Aziz The Lancet, 2015 | 5497 | 2015 |
| Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global … H Wang, M Naghavi, C Allen, RM Barber, ZA Bhutta, A Carter, DC Casey, ... The lancet 388 (10053), 1459-1544, 2016 | 5219 | 2016 |
| Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying … CJL Murray, RM Barber, KJ Foreman, AA Ozgoren, F Abd-Allah, SF Abera, ... The Lancet 386 (10009), 2145-2191, 2015 | 2354* | 2015 |
| Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010 JA Salomon, T Vos, DR Hogan, M Gagnon, M Naghavi, A Mokdad, ... The Lancet 380 (9859), 2129-2143, 2012 | 1562 | 2012 |
| Global, regional, and national burden of rheumatic heart disease, 1990–2015 DA Watkins, CO Johnson, SM Colquhoun, G Karthikeyan, A Beaton, ... New England Journal of Medicine 377 (8), 713-722, 2017 | 1086 | 2017 |
| Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of … H Wang, AA Abajobir, KH Abate, C Abbafati, KM Abbas, F Abd-Allah, ... The Lancet 390 (10100), 1084-1150, 2017 | 875 | 2017 |
| Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990 … GBD 2013 Risk Factors Collaborators Lancet (London, England) 386 (10010), 2287, 2015 | 759 | 2015 |
| Acute rheumatic fever and rheumatic heart disease JR Carapetis, A Beaton, MW Cunningham, L Guilherme, G Karthikeyan, ... Nature reviews Disease primers 2 (1), 1-24, 2016 | 571 | 2016 |
| Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study) L Zühlke, ME Engel, G Karthikeyan, S Rangarajan, P Mackie, B Cupido, ... European heart journal 36 (18), 1115-1122, 2015 | 542 | 2015 |
| Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial RP Whitlock, PJ Devereaux, KH Teoh, A Lamy, J Vincent, J Pogue, ... The Lancet 386 (10000), 1243-1253, 2015 | 355 | 2015 |
| Is a pre-operative brain natriuretic peptide or N-terminal pro–B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days … G Karthikeyan, RA Moncur, O Levine, D Heels-Ansdell, MTV Chan, ... Journal of the American College of Cardiology 54 (17), 1599-1606, 2009 | 325 | 2009 |
| Clinical outcomes in 3343 children and adults with rheumatic heart disease from 14 low-and middle-income countries: two-year follow-up of the Global Rheumatic Heart Disease … L Zühlke, G Karthikeyan, ME Engel, S Rangarajan, P Mackie, ... Circulation 134 (19), 1456-1466, 2016 | 276 | 2016 |
| Lipid profile, plasma apolipoproteins, and risk of a first myocardial infarction among Asians: an analysis from the INTERHEART Study G Karthikeyan, KK Teo, S Islam, MJ McQueen, P Pais, X Wang, H Sato, ... Journal of the American College of Cardiology 53 (3), 244-253, 2009 | 273 | 2009 |
| American Association of Orthopedic Surgeons and American College of Chest Physicians guidelines for venous thromboembolism prevention in hip and knee arthroplasty differ: what … JW Eikelboom, G Karthikeyan, N Fagel, J Hirsh Chest 135 (2), 513-520, 2009 | 270 | 2009 |
